before their second cohort visit (group B). In group A, predictors for low initial CD4 cell counts were examined with a median regression. In group B, we studied predictors for CD4o200 cells/mL without ART despite cohort follow-up. Results Median initial CD4 cell count in group A was 331 cells/mL; 31 % and 10 % wereo200 ando50 cells/mL, respectively. Risk factors for low CD4 count were age and non-White race. Homosexual transmission, intravenous drug use and living alone were protective. In group B, 30 % initiated ART with CD4 200 cells/mL; 18 % and 2 % dropped to CD4 o200 and o50 cells/mL without ART, respectively. Sub-Saharan origin was associated with lower probability of CD4 o200 cells/mL without ART during follow-up. Median CD4 count ...
Background: CD4 cell recovery following first-line combination ART (cART) is poorer in HIV-2+ than i...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
Introduction: Although antiretroviral therapy (ART) has been rapidly scaled up in Asia, most HIV-pos...
Introduction Clinical disadvantages of initiating ART at low CD4 counts have been clearly demonstrat...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
<p>At each individual time points, the observed median CD4 cell counts were significantly higher in ...
BACKGROUND: CD4 cell count recovery after antiretroviral therapy (ART) initiation is associated with...
<p>Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count >350 cell...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
<p>Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeD...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0122583#pone.0122583.g001" ...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
BACKGROUND: Estimates of the decrease in CD4(+) cell counts in untreated patients with human immunod...
BACKGROUND: Estimates of the decrease in CD4(+) cell counts in untreated patients with human immunod...
We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...
Background: CD4 cell recovery following first-line combination ART (cART) is poorer in HIV-2+ than i...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
Introduction: Although antiretroviral therapy (ART) has been rapidly scaled up in Asia, most HIV-pos...
Introduction Clinical disadvantages of initiating ART at low CD4 counts have been clearly demonstrat...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
<p>At each individual time points, the observed median CD4 cell counts were significantly higher in ...
BACKGROUND: CD4 cell count recovery after antiretroviral therapy (ART) initiation is associated with...
<p>Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count >350 cell...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
<p>Median CD4 count (cells/µl) and interquartile range, from ART initiation in the HIV-2 cohort, IeD...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0122583#pone.0122583.g001" ...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
BACKGROUND: Estimates of the decrease in CD4(+) cell counts in untreated patients with human immunod...
BACKGROUND: Estimates of the decrease in CD4(+) cell counts in untreated patients with human immunod...
We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...
Background: CD4 cell recovery following first-line combination ART (cART) is poorer in HIV-2+ than i...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
Introduction: Although antiretroviral therapy (ART) has been rapidly scaled up in Asia, most HIV-pos...